$3.31T
Total marketcap
$93.46B
Total volume
BTC 57.42%     ETH 11.98%
Dominance

BioMarin Pharmaceutical BMRN Stock

$55.47   0.726351%
Add to favorites
Market Cap
$11.33B
LOW - HIGH [24H]
$58.87 - $60.07
VOLUME [24H]
$383.76K
P/E Ratio
21.92
Earnings per share
$2.69
Price   Prediction

BioMarin Pharmaceutical Price Chart

Sorry, that's all we've gotfor now...

BioMarin Pharmaceutical BMRN Financial and Trading Overview

BioMarin Pharmaceutical stock price 55.47 USD
Previous Close {summary_details__previousClose}
Open {summary_details__open}
Bid {summary_details__bid} x {summary_details__bidSize}
Ask {summary_details__ask} x {summary_details__askSize}
Day's Range 57.02 - 58.79 USD
52 Week Range 52.93 - 94.85 USD
Volume {summary_details__volume}
Avg. Volume {summary_details__averageVolume}
Market Cap {summary_details__marketCap}
Beta (5Y Monthly) {summary_details__beta}
PE Ratio (TTM) {summary_details__trailingPE}
EPS (TTM) 2.69 USD
Forward Dividend & Yield {summary_details__dividendRate} ({summary_details__dividendYield})
Ex-Dividend Date {summary_details__exDividendDate}
1y Target Est {financial_data__targetMeanPrice}

BMRN Valuation Measures

Enterprise Value {default_key_statistics__enterpriseValue}
Trailing P/E {summary_details__trailingPE}
Forward P/E {summary_details__forwardPE}
PEG Ratio (5 yr expected) {default_key_statistics__pegRatio}
Price/Sales (ttm) {summary_details__priceToSalesTrailing12Months}
Price/Book (mrq) {default_key_statistics__priceToBook}
Enterprise Value/Revenue {default_key_statistics__enterpriseToRevenue}
Enterprise Value/EBITDA {default_key_statistics__enterpriseToEbitda}

Trading Information

BioMarin Pharmaceutical Stock Price History

Beta (5Y Monthly) {default_key_statistics__beta}
52-Week Change {default_key_statistics__52WeekChange}
S&P500 52-Week Change {default_key_statistics__SandP52WeekChange}
52 Week High {summary_details__fiftyTwoWeekHigh}
52 Week Low {summary_details__fiftyTwoWeekLow}
50-Day Moving Average {summary_details__fiftyDayAverage}
200-Day Moving Average {summary_details__twoHundredDayAverage}

BMRN Share Statistics

Avg. Volume (3 month) {summary_details__averageVolume}
Avg. Daily Volume (10-Days) {summary_details__averageDailyVolume10Day}
Shares Outstanding {default_key_statistics__sharesOutstanding}
Float {default_key_statistics__floatShares}
Short Ratio {default_key_statistics__shortRatio}
% Held by Insiders {default_key_statistics__heldPercentInsiders}
% Held by Institutions {default_key_statistics__heldPercentInstitutions}
Shares Short {default_key_statistics__sharesShort}
Short % of Float {default_key_statistics__shortPercentOfFloat}
Short % of Shares Outstanding {default_key_statistics__sharesPercentSharesOut}

Dividends & Splits

Trailing Annual Dividend Rate {summary_details__trailingAnnualDividendRate}
Trailing Annual Dividend Yield {summary_details__trailingAnnualDividendYield}
5 Year Average Dividend Yield {summary_details__fiveYearAvgDividendYield}
Payout Ratio {summary_details__payoutRatio}
Last Split Factor {default_key_statistics__lastSplitFactor}

Financial Highlights

Fiscal Year

Fiscal Year Ends {default_key_statistics__lastFiscalYearEnd}
Most Recent Quarter (mrq) {default_key_statistics__mostRecentQuarter}
Next Fiscal Year End {default_key_statistics__nextFiscalYearEnd}

Profitability

Profit Margin {financial_data__profitMargins}
Operating Margin (ttm) {financial_data__operatingMargins}
Gross Margin {financial_data__grossMargins}
EBITDA Margin {financial_data__ebitdaMargins}

Management Effectiveness

Return on Assets (ttm) {financial_data__returnOnAssets}
Return on Equity (ttm) {financial_data__returnOnEquity}

Income Statement

Revenue (ttm) {financial_data__totalRevenue}
Revenue Per Share (ttm) {financial_data__revenuePerShare}
Quarterly Revenue Growth (yoy) {financial_data__revenueGrowth}
Gross Profit (ttm) {financial_data__grossProfits}
EBITDA {financial_data__ebitda}
Net Income Avi to Common (ttm) {default_key_statistics__netIncomeToCommon}
Diluted EPS (ttm) {default_key_statistics__trailingEps}
Quarterly Earnings Growth (yoy) {default_key_statistics__earningsQuarterlyGrowth}

Balance Sheet

Total Cash (mrq) {financial_data__totalCash}
Total Cash Per Share (mrq) {financial_data__totalCashPerShare}
Total Debt (mrq) {financial_data__totalDebt}
Total Debt/Equity (mrq) {financial_data__debtToEquity}
Current Ratio (mrq) {financial_data__currentRatio}
Book Value Per Share (mrq) {default_key_statistics__bookValue}

Cash Flow Statement

Operating Cash Flow (ttm) {financial_data__operatingCashflow}
Levered Free Cash Flow (ttm) {financial_data__freeCashflow}

Profile of BioMarin Pharmaceutical

Country United States
State {summary_profile__state}
City {summary_profile__city}
Address {summary_profile__address1}
ZIP {summary_profile__zip}
Phone {summary_profile__phone}
Website {summary_profile__website}
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees {summary_profile__fullTimeEmployees}

{summary_profile__longBusinessSummary}

Q&A For BioMarin Pharmaceutical Stock

What is a current BMRN stock price?

BioMarin Pharmaceutical BMRN stock price today per share is 55.47 USD.

How to purchase BioMarin Pharmaceutical stock?

You can buy BMRN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BioMarin Pharmaceutical?

The stock symbol or ticker of BioMarin Pharmaceutical is BMRN.

Which industry does the BioMarin Pharmaceutical company belong to?

The BioMarin Pharmaceutical industry is Biotechnology.

How many shares does BioMarin Pharmaceutical have in circulation?

The max supply of BioMarin Pharmaceutical shares is 204.31M.

What is BioMarin Pharmaceutical Price to Earnings Ratio (PE Ratio)?

BioMarin Pharmaceutical PE Ratio is 21.92936900 now.

What was BioMarin Pharmaceutical earnings per share over the trailing 12 months (TTM)?

BioMarin Pharmaceutical EPS is 2.69 USD over the trailing 12 months.

Which sector does the BioMarin Pharmaceutical company belong to?

The BioMarin Pharmaceutical sector is Healthcare.

BioMarin Pharmaceutical BMRN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
US Tech Composite IXIC 23419.08 USD
-0.24
6.09B USD 23414.83 USD 23521.05 USD 6.09B USD
Dow Jones U.S. Biotechnology In DJUSBT 3173.43 USD
-0.58
48.37M USD 3161.44 USD 3187.48 USD 48.37M USD
Stlmt ID US Tech Biotechnology NBX 3995.9 USD
-4.37
4555.41 USD 4917.8 USD
US Tech Biotechnology Total Retu XNBI 6208.94 USD
-1.03
6194.25 USD 6259.9 USD
US Tech Q-50 NXTQ 978.19 USD
-0.48
978.02 USD 983.73 USD
US Tech Global Select Market Com NQGS 11479.19 USD
-0.21
11477.01 USD 11527.15 USD
US Tech Next Generation 100 Inde NGX 1504.62 USD
-0.29
1504.38 USD 1512.61 USD
US Tech Biotechnology NBI 5707.25 USD
-1.03
5693.75 USD 5754.1 USD
US Tech Health Care IXHC 1187.51 USD
-0.86
1185.41 USD 1195.34 USD
US Tech Composite Total Return XCMP 28797.52 USD
-0.24
28792.3 USD 28922.91 USD
US Tech US Smart Pharmaceuticals NQSSPH 1765.99 USD
-0.66
1762.18 USD 1776.43 USD
US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
✨New! Portfolio🚀